At the forefront of innovation
Nanoimmunotech´s main contribution is related to validation and nanosafety characterization (in vitro and in vivo) of the use of new surfactants in nanoparticle synthesis for pharma applications.
Nanoimmunotech´s main contribution is related to validation and nanosafety characterization (in vitro and in vivo) of the use of new surfactants in nanoparticle synthesis for pharma applications.